BRPI0610177A2 - composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissomo - Google Patents
composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissomoInfo
- Publication number
- BRPI0610177A2 BRPI0610177A2 BRPI0610177A BRPI0610177A BRPI0610177A2 BR PI0610177 A2 BRPI0610177 A2 BR PI0610177A2 BR PI0610177 A BRPI0610177 A BR PI0610177A BR PI0610177 A BRPI0610177 A BR PI0610177A BR PI0610177 A2 BRPI0610177 A2 BR PI0610177A2
- Authority
- BR
- Brazil
- Prior art keywords
- salt
- compound
- activated receptor
- peroxisome proliferator
- receptor activator
- Prior art date
Links
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 title 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005152949 | 2005-05-25 | ||
| PCT/JP2006/310822 WO2006126714A1 (ja) | 2005-05-25 | 2006-05-24 | ペルオキシソーム増殖剤活性化受容体の活性化剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0610177A2 true BRPI0610177A2 (pt) | 2016-11-29 |
Family
ID=37452127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0610177A BRPI0610177A2 (pt) | 2005-05-25 | 2006-05-24 | composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissomo |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20090203908A1 (pt) |
| EP (1) | EP1897872A1 (pt) |
| JP (1) | JPWO2006126714A1 (pt) |
| KR (1) | KR20080014075A (pt) |
| CN (1) | CN101228144A (pt) |
| AU (1) | AU2006250373A1 (pt) |
| BR (1) | BRPI0610177A2 (pt) |
| CA (1) | CA2609446A1 (pt) |
| IL (1) | IL187530A0 (pt) |
| NO (1) | NO20076632L (pt) |
| RU (1) | RU2007148439A (pt) |
| WO (1) | WO2006126714A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010042925A2 (en) | 2008-10-10 | 2010-04-15 | Vm Discovery Inc. | Compositions and methods for treating alcohol use disorders, pain and other diseases |
| CN102724978A (zh) * | 2009-08-14 | 2012-10-10 | 塞伦尼斯治疗公司 | 用于治疗或预防炎症或能量代谢/产生相关疾病的PPARδ配体的用途 |
| US11634387B2 (en) | 2019-09-26 | 2023-04-25 | Abionyx Pharma Sa | Compounds useful for treating liver diseases |
| WO2022189856A1 (en) * | 2021-03-08 | 2022-09-15 | Abionyx Pharma Sa | Compounds useful for treating liver diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1310494B1 (en) * | 2000-08-11 | 2012-01-25 | Nippon Chemiphar Co., Ltd. | PPAR (delta) ACTIVATORS |
| GB0031103D0 (en) * | 2000-12-20 | 2001-01-31 | Glaxo Group Ltd | Chemical compounds |
| US7078422B2 (en) * | 2001-03-23 | 2006-07-18 | Nippon Chemiphar Co., Ltd. | Activator for peroxisome proliferator-activated receptor |
| GB0111523D0 (en) * | 2001-05-11 | 2001-07-04 | Glaxo Group Ltd | Chemical compounds |
| BRPI0211844B8 (pt) * | 2001-08-10 | 2021-05-25 | Nippon Chemiphar Co | composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica |
-
2006
- 2006-05-24 KR KR1020077030183A patent/KR20080014075A/ko not_active Withdrawn
- 2006-05-24 US US11/920,940 patent/US20090203908A1/en not_active Abandoned
- 2006-05-24 AU AU2006250373A patent/AU2006250373A1/en not_active Abandoned
- 2006-05-24 WO PCT/JP2006/310822 patent/WO2006126714A1/ja not_active Ceased
- 2006-05-24 JP JP2007517933A patent/JPWO2006126714A1/ja active Pending
- 2006-05-24 CN CNA2006800266598A patent/CN101228144A/zh active Pending
- 2006-05-24 RU RU2007148439/04A patent/RU2007148439A/ru not_active Application Discontinuation
- 2006-05-24 BR BRPI0610177A patent/BRPI0610177A2/pt not_active IP Right Cessation
- 2006-05-24 EP EP06756770A patent/EP1897872A1/en not_active Withdrawn
- 2006-05-24 CA CA002609446A patent/CA2609446A1/en not_active Abandoned
-
2007
- 2007-11-20 IL IL187530A patent/IL187530A0/en unknown
- 2007-12-21 NO NO20076632A patent/NO20076632L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080014075A (ko) | 2008-02-13 |
| EP1897872A1 (en) | 2008-03-12 |
| IL187530A0 (en) | 2008-03-20 |
| NO20076632L (no) | 2008-02-15 |
| JPWO2006126714A1 (ja) | 2008-12-25 |
| WO2006126714A1 (ja) | 2006-11-30 |
| CN101228144A (zh) | 2008-07-23 |
| RU2007148439A (ru) | 2009-06-27 |
| US20090203908A1 (en) | 2009-08-13 |
| AU2006250373A1 (en) | 2006-11-30 |
| CA2609446A1 (en) | 2006-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC2343304I2 (lt) | Biocidiniai boronoftalido junginiai | |
| BRPI0717757A2 (pt) | Derivado de haloalquilsulfoanilida ou um sal do mesmo, herbicida, e, método para usar um herbicida | |
| BRPI0716171A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto. | |
| BRPI0822033A2 (pt) | Composto ou sal do mesmo, composição farmacêutica, uso de um composto ou sal, e, kit | |
| IL194847A0 (en) | Activating agent for peroxisome proliferator activated receptor ?? | |
| BRPI0815709A2 (pt) | composro, composição farmacêutica, e, uso de um composto. | |
| BRPI0609802A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| BRPI0618904A2 (pt) | composto, composição farmacêutica, e, uso do composto | |
| BRPI0614205A2 (pt) | composto, composição farmacêutica, e, uso de composto | |
| BRPI0812877A2 (pt) | " compostos de piperazina, uso de um composto de piperazina, composição, e, método para combater vegetação indesejada ". | |
| ES1060473Y (es) | Red de proteccion, especialmente para proteccion frente a la caida de piedras o para aseguramiento de taludes. | |
| BRPI0607545A2 (pt) | composto, uso de um composto de fórmula i ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica | |
| BRPI0815957A2 (pt) | "composto, composição farmacêutica, métodos e respectivo uso de 1,2,3-triazin-4-onas trissubstituídas e 1,3-pirimidinonas trissubstituídas para a melhora das respostas sinápticas glutamatérgicas" | |
| BRPI0614730A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| DE112007002677A5 (de) | Tierleine, insbesondere Hundeleine | |
| BRPI0610177A2 (pt) | composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissomo | |
| BRPI0609178A2 (pt) | composto ou um sal do mesmo, e, ativador para o receptor ativado do proliferador de peroxissoma delta | |
| BRPI0612396A2 (pt) | composto ou um sal do mesmo, e, ativador para receptor ativado por proliferador de peroxissoma delta | |
| BRPI0612406A2 (pt) | sal de estrôncio, e, uso do mesmo | |
| BRPI0816800A2 (pt) | Composto, composição farmacêutica, e, uso de um composto. | |
| BRPI0821667A2 (pt) | Derivado de 15, 16-metileno-17-(1'-propenil)-17,3'-oxidoestra-4-em-3-on a, seu uso e medicamentos contendo o derivado | |
| DE502006000922D1 (de) | Richtung | |
| BRPI0612270A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| ES1059541Y (es) | Caja-contenedor perfeccionada para pescado | |
| BRPI0611841A2 (pt) | processos para isolar um sal, para preparar um sal, e para a preparação de um composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA. |
|
| B11Z | Dismissal: petition dismissal - article 216, par 2 of industrial property law |
Free format text: REFERENTE A PETICAO NO 20070165842/RJ DE 23/11/2007. |
|
| B11M | Decision cancelled [chapter 11.13 patent gazette] |
Free format text: ANULADA A PUBLICACAO 11.6.1 NA RPI 2178 DE 02/10/2012, POR TER SIDO INDEVIDA |
|
| B06H | Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette] |
Free format text: ANULADA A PUBLICACAO 6.7 NA RPI 2138 DE 27/12/2011, POR TER SIDO INDEVIDA |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |